Copyright
©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 96369
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.96369
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.96369
Table 1 Clinical, laboratory, and histopathological characteristics
Parameter | Value |
Hepatomegaly | 24 (26.9) |
Splenomegaly | 19 (23.5) |
Ascites | 0.0 |
Aspartate transaminase (U/L) | 49.72 ± 42.67 |
Alanine transaminase (U/L) | 58.36 ± 56.40 |
Prothrombin time (second) | 13.01 ± 1.16 |
Hemoglobin (g/dL) | 12.42 ± 1.50 |
White blood cells (× 103/mm3) | 7.04 ± 2.46 |
Platelets (× 103/mm3) | 267.96 ± 102.50 |
PCR (U/mL | 827319.64 ± 2415665.23 |
Fibrosis stage | |
F1 | 17 (26.5) |
F2 | 36 (56.3) |
F3 | 11 (17.2) |
Activity grade | |
Absent: A0 | 1 (16.0) |
Minimal: A1-A3 | 14 (21.9) |
Mild: A4-A8 | 44 (68.8) |
Moderate: A9-A12 | 5 (7.8) |
Severe: A12-A18 | 0 (0) |
Table 2 Liver stiffness, and liver and spleen apparent diffusion coefficient in different fibrosis stages
Noninvasive parameter | F1, n = 17 | F2, n = 36 | F3, n = 11 | aP value |
LSM (kPa) | 4.04 ± 1.41 | 4.98 ± 1.63 | 7.20 ± 5.21 | 0.034 |
bP = 0.096 | cP = 0.035 | |||
Liver ADC (mm2/s) | 1.12 ± 0.24 | 1.15 ± 0.23 | 0.95 ± 0.22 | 0.039 |
bP = 0.0787 | cP = 0.017 | |||
Spleen ADC (mm2/s) | 1.12 ± 0.23 | 1.01 ± 0.15 | 0.99 ± 0.26 | 0.271 |
Normalized liver ADC | 1.01 ± 0.22 | 1.16 ± 0.23 | 0.99 ± 0.25 | 0.036 |
bP = 0.033 | cP = 0.016 | |||
APRI score | 0.44 ± 0.42 | 0.48 ± 0.29 | 0.38 ± 0.37 | 0.332 |
FIB-4 score | 0.34 ± 0.30 | 0.34 ± 0.15 | 0.22 ± 0.16 | 0.083 |
Table 3 Correlation of fibrosis and activity with different studied parameters
Parameters | Fibrosis | Activity | ||
R value | P value | R value | P value | |
Age in yr | 0.068 | 0.594 | 0.159 | 0.208 |
Aspartate transaminase (U/L) | -0.044 | 0.751 | 0.192 | 0.160 |
Alanine transaminase (U/L) | 0.092 | 0.501 | 0.242 | 0.073 |
Prothrombin time (second) | -0.066 | 0.637 | -0.184 | 0.188 |
Hemoglobin (g/dL) | 0.041 | 0.764 | -0.050 | 0.718 |
White blood cells as × 103/mm3 | 0.680 | 0.620 | 0.015 | 0.913 |
Platelets as × 103/mm3 | 0.047 | 0.731 | -0.032 | 0.815 |
LSM (kPa) | 0.338 | 0.008 | 0.385 | 0.002 |
Liver ADC (mm2/s) | -0.299 | 0.086 | -0.281 | 0.840 |
Spleen ADC (mm2/s) | -0.212 | 0.145 | -0.019 | 0.897 |
Normalized liver ADC | -0.064 | 0.653 | -0.148 | 0.300 |
APRI score | -0.003 | 0.984 | -0.088 | 0.549 |
FIB-4 score | -0.128 | 0.376 | 0.148 | 0.305 |
- Citation: El-Guindi MA, Allam AA, Abdel-Razek AA, Sobhy GA, Salem ME, Abd-Allah MA, Sira MM. Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C. World J Virol 2024; 13(3): 96369
- URL: https://www.wjgnet.com/2220-3249/full/v13/i3/96369.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i3.96369